ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB391

Hyaluronan Synthase-1 Contributes to Tubulointerstitial Fibrosis in a Murine Model of CKD

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Xu, Yuesong, Department of Medicine, The University of Hong Kong, Hong Kong SAR, Hong Kong
  • Yung, Susan, Department of Medicine, The University of Hong Kong, Hong Kong SAR, Hong Kong
  • Chan, Tak Mao Daniel, Department of Medicine, The University of Hong Kong, Hong Kong SAR, Hong Kong
Background

Chronic kidney disease (CKD) is characterized by progressive tubulo-interstitial fibrosis leading to end-stage kidney disease. Mechanisms that initiate tubulo-interstitial fibrosis remains to be fully defined. We previously demonstrated that hyaluronan (HA) expression was increased in murine models of CKD and deletion of HA synthase-1 (HAS-1), an enzyme that synthesizes HA, attenuated histopathological changes and mediators of inflammation and fibrosis. This study compared transcriptomic profiling and molecular pathways in wild-type (WT) and HAS-1 knockout (KO) mice with CKD.

Methods

CKD was induced in male WT and HAS-1 KO mice by feeding with casein-based chow containing 0.2% adenine for 12 weeks, after which time kidneys were harvested. Mice fed casein-based chow served as non-CKD controls. Total RNA was extracted from renal cortical tissue and subjected to bulk RNA-sequencing. Differentially expressed genes (DEGs) were identified based on ±1.2-fold change and adjusted p-value < 0.05 . Enrichment analyses were conducted for GO category genes and KEGG pathways.

Results

Transcriptomic analysis identified a total of 11,783 DEGs (6,322 up-regulated genes and 5,461 down-regulated genes) in WT CKD mice compared to WT control mice (padj <0.05). Genes that were up-regulated included col1a1, col1a2, col3a1, dcn, fn1, lama2, lamb3, and lamc2 (padj<0.001). WT CKD mice showed GO enrichment in categories related to extracellular matrix (ECM) organization, immune response regulation and fibroblast proliferation (padj<0.001), and KEGG pathways such as cytokine-cytokine receptor interaction, ECM-receptor interaction, PI3K/AKT and MAPK signaling (padj<0.001). These GO and KEGG pathways were significantly altered in HAS-1 KO CKD mice (padj<0.001). Western blot analysis revealed increased phosphorylation of PI3K/AKT and p38 MAPK in WT CKD mice, which was significantly reduced in HAS-1 KO CKD mice.

Conclusion

Our findings suggest that increased HAS-1 activity contributes to tubulo-interstitial fibrosis through up-regulation of ECM organization and induction of PI3K/AKT and p38 MAPK signaling.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)